Subscription Agreement for T1 bis [Shares] [Pre-Funded Warrants]Subscription Agreement • December 16th, 2024 • Inventiva S.A. • Pharmaceutical preparations
Inventiva S.A., a société anonyme organized under the laws of the French Republic, with a share capital of €870,776.95, consisting of 87,077,695 ordinary shares of €0.01 nominal value each (the “Ordinary Shares” and each, an “Ordinary Share”), and registered with the Commerce and Companies Registry of Dijon under the number 537 530 255 (the “Company”) has issued pursuant to the decision of the Company’s board of directors (the “Board of Directors”) held on October 11, 2024, 34,600,507 new Ordinary Shares (each, a “T1 Share” and collectively, the “T1 Shares”) and 35,399,481 pre-funded warrants to purchase up to 35,399,481 Ordinary Shares (each a “T1 Pre-Funded Warrant” and collectively, the “T1 Pre-Funded Warrants”), for a subscription price of €1.35 per T1 Share (the “T1 Subscription Price”) and of €1.34 (i.e., T1 Subscription Price less the nominal value of an Ordinary Share) per Pre-Funded Warrant (the “T1 Pre-Funded Subscription Price”), for an aggregate amount of €94,145,988.99 as
